| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Recursion Pharmaceuticals, Inc. (RXRX) have been net sellers, shedding 127,408 shares worth roughly $546K on balance. In the past 30 days, 0 insiders bought and 2 sold. The bias lately has been to the sell side.
All 2 insiders who sold still hold shares after their sales. RXRX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.11M | $29.56M | -50,000 | |
| CEO | 2.07M | $7.29M | - | |
| Dir | 1.48M | - | - | |
| CFO | 1.07M | $3.65M | - | |
| Other | 1.04M | $3.30M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2024 | Virani Shafique70 | Chief Business Officer | Sale+OE10b5-1 | 18,000 | $10.93 | $196,740.00 | -11.6% | -27.6% | -40.3% | |
| Jan 9, 2024 | Li Dean Y78 | Director | Sell10b5-1 | 29,000 | $13.66 | $396,213.83 | -6.4% | -32.8% | -45.8% | |
| Jan 9, 2024 | Borgeson Blake68 | Director | Sell10b5-1 | 20,054 | $13.62 | $273,202.44 | -0.3% | -32.8% | -45.8% | |
| Jan 3, 2024 | Gibson Christopher71 | Chief Executive Officer | Sale+OE | 55,853 | $9.50 | $530,567.33 | - | -9.5% | -25.6% | |
| Dec 28, 2023 | Larson Tina Marriott73 | President and COO | Sale+OE10b5-1 | 8,000 | $10.58 | $84,653.60 | -1.9% | -4.1% | -30.3% | |
| Dec 26, 2023 | Borgeson Blake68 | Director | Sell10b5-1 | 20,054 | $10.63 | $213,143.94 | -0.3% | -2.4% | -29.0% | |
| Dec 15, 2023 | Virani Shafique70 | Chief Business Officer | Sale+OE10b5-1 | 18,000 | $9.60 | $172,800.00 | -11.6% | +11.1% | -28.4% | |
| Dec 14, 2023 | Dar Zavain | Director | Sell10b5-1 | 20,141 | $9.00 | $181,269.00 | -27.2% | +15.2% | -27.1% | |
| Dec 13, 2023 | Secora Michael74 | Chief Financial Officer | Sale+OE10b5-1 | 50,000 | $7.49 | $374,637.50 | -5.0% | +26.5% | -16.2% | |
| Dec 12, 2023 | Borgeson Blake68 | Director | Sell10b5-1 | 11,447 | $7.40 | $84,692.92 | -0.2% | +39.4% | +1.7% |